The National Institutes of Health (NIH) is offering the Trans-Agency Blood-Brain Interface Program Grant to support innovative research on the neurovascular-blood unit, focusing on the Blood-Brain Barrier (BBB). The grant aims to advance understanding of the vascular, hemostatic, hematopoietic, and immune cell interactions at the BBB in normal and pathological conditions. By creating enhanced human BBB models, this program seeks to redefine the neurovascular unit and develop advanced pre-clinical cellular systems. Applications for this grant must be submitted by December 21, 2021, 12:00 AM EST.
Opportunity ID: 320214
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-HL-20-021 |
Funding Opportunity Title: | Trans-Agency Blood-Brain Interface Program (R61/R33 – Clinical Trials Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 03, 2019 |
Last Updated Date: | Sep 03, 2019 |
Original Closing Date for Applications: | Dec 21, 2021 |
Current Closing Date for Applications: | Dec 21, 2021 |
Archive Date: | Jan 26, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $425,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal governments (Federally recognized) City or township governments Private institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts State governments For profit organizations other than small businesses Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support high risk/high reward research on the blood/vascular component and regulation of the neurovascular-blood unit (a.k.a., Blood-Brain Barrier; BBB) in normal and pathological states to create enhanced/modified platforms that more closely model the human BBB. Research addressing vascular, hemostatic, hematopoietic, and/or immune cell interaction across the Blood-Brain Interface is of particular interest. This initiative will serve to stimulate the development of a new field of science and re-define the neurovascular unit to also include the blood/vascular component to develop the next generation of pre-clinical human cellular model systems of the human BBB to complement research currently based on animal models. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-021.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00260354 | Sep 17, 2019 | Jan 24, 2022 | View | |
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00254499 | Sep 17, 2019 | May 24, 2020 | View | |
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270598 | Nov 22, 2021 | Dec 21, 2021 | View |
Package 1
Mandatory forms
320214 RR_SF424_2_0-2.0.pdf
320214 PHS398_CoverPageSupplement_5_0-5.0.pdf
320214 RR_OtherProjectInfo_1_4-1.4.pdf
320214 PerformanceSite_2_0-2.0.pdf
320214 RR_KeyPersonExpanded_2_0-2.0.pdf
320214 RR_Budget_1_4-1.4.pdf
320214 PHS398_ResearchPlan_4_0-4.0.pdf
320214 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
320214 RR_SubawardBudget30_1_4-1.4.pdf
320214 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
320214 RR_SF424_2_0-2.0.pdf
320214 PHS398_CoverPageSupplement_4_0-4.0.pdf
320214 RR_OtherProjectInfo_1_4-1.4.pdf
320214 PerformanceSite_2_0-2.0.pdf
320214 RR_KeyPersonExpanded_2_0-2.0.pdf
320214 RR_Budget_1_4-1.4.pdf
320214 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
320214 RR_SubawardBudget30_1_4-1.4.pdf
320214 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
320214 RR_SF424_5_0-5.0.pdf
320214 PHS398_CoverPageSupplement_5_0-5.0.pdf
320214 RR_OtherProjectInfo_1_4-1.4.pdf
320214 PerformanceSite_4_0-4.0.pdf
320214 RR_KeyPersonExpanded_4_0-4.0.pdf
320214 RR_Budget_3_0-3.0.pdf
320214 PHS398_ResearchPlan_4_0-4.0.pdf
320214 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
320214 RR_SubawardBudget30_3_0-3.0.pdf
320214 PHS_AssignmentRequestForm_3_0-3.0.pdf